Home / 2024 (Page 45)

According to a study, 2/3rd of Indian Adults are unaware of Adult Vaccination Hyderabad, 29th July, 2024: Rainbow Children’s Hospital, one of the pioneers of Pediatric care in India launched AVON – Adult Vaccination Outreach Network with a mission to vaccinate the adult population in the

READ MORE

HCG Aastha Cancer Centre Ahmedabad successfully hosted the 9th edition of the Oncosurgery Mastercourse (OM 9.0), a masterclass dedicated to the specialized field of salivary gland tumours. Given the surgical demands of salivary gland tumours, which require pinnacle of surgical skills, OM 9.0 aimed to

READ MORE

Attributed to Dr. Brajmohan Singh, Sr. Cardiothoracic & Vascular Surgeon, HCG Hospitals, Ahmedabad The human heart is a muscular organ that powers the circulatory system, working tirelessly to pump blood through a vast network of vessels. Cardiovascular diseases, such as coronary artery disease, heart attacks, arrhythmias,

READ MORE

HCG Cancer Centre Jaipur unveiled an indigenous scalp cooling therapy, making it the first in Rajasthan to offer this revolutionary treatment for chemotherapy patients. This advanced therapy is designed to reduce hair loss and promote quicker hair regrowth due to chemotherapy. This technology was officially

READ MORE

Dr Chitra Ramamurthy, Senior Consultant- Fertility & IVF, Apollo Fertility JP Nagar, Bengaluru Infertility affects millions of individuals and couples worldwide, posing significant challenges to achieving parenthood naturally. In such cases, In Vitro Fertilization (IVF) emerges as a viable treatment option, offering hope and a pathway

READ MORE

Fischer Medical Ventures Ltd (formerly known as Fischer Chemic Limited), through its wholly owned subsidiary Time Medical International Ventures (India) Private Limited formalises its investment in Health Digital Technologies (HDT), joining their existing investors Samsung Ventures and sovereign wealth fund of Malaysia, Khazanah (through MTDC),

READ MORE

Gland Pharma Limited (Gland or Company), a generic injectable-focused pharmaceutical company, has received tentative approval from the United States Food and Drug Administration (USFDA) for Latanoprostene Bunod Ophthalmic Solution, 0.024%. The Product is bioequivalent and therapeutically equivalent to the reference listed drug (RLD), Vyzulta® Ophthalmic Solution,

READ MORE

 RUSAN PHARMA PRIVATE LIMITED, a pharmaceutical company based in India specializing in the area of addiction treatment and pain management, recently announced that the United States Food and Drug Administration (US FDA) has granted Good Manufacturing Practice (GMP) approval for its Active Pharmaceutical Ingredient (API)

READ MORE

Dr. Raj Nagarkar, Managing Director and Chief of Surgical Oncology and Robotic Services, HCG Manavata Cancer Centre, Nashik Diabetes isn't just about watching sugar intake—it's a serious health concern with far-reaching implications. For women, there's an added risk: diabetes has been linked to an increased chance

READ MORE